CB2-receptor agonist LE-102 restricts lesion progression after transient MCAO - A randomized controlled preclinical trial E. Van Leeuwen,A. Meerwaldt,C. Van Heijningen, L. de Paus, A. van der Toorn,W. Mulder,M. van der Stelt,R. DijkhuizenJOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM（2022）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
